Abdominal Obesity Metabolic Syndrome
Welcome,         Profile    Billing    Logout  
 26 Companies   51 Products   51 Products   56 Mechanisms of Action   3 Trials   839 News 


«12...4567891011121314...1617»
  • ||||||||||  omega-3 ethylester concentrate / Generic mfg.
    Enrollment closed, Trial primary completion date:  HEARTS: Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids (clinicaltrials.gov) -  Jan 28, 2015   
    P3,  N=338, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> May 2015
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date, MRI:  MRIPD#7: Magnetic Resonance Imaging-Portfolio Diet Study #7 (clinicaltrials.gov) -  Jan 20, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Oct 2015 N=194 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2018 --> Dec 2014
  • ||||||||||  Trial primary completion date:  Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk (clinicaltrials.gov) -  Jan 13, 2015   
    P2,  N=28, Recruiting, 
    N=194 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2018 --> Dec 2014 Trial primary completion date: Dec 2014 --> Mar 2015
  • ||||||||||  Trial primary completion date:  Metabolically Normal and Metabolically Abnormal Obesity (clinicaltrials.gov) -  Jan 2, 2015   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Dec 2014 --> Mar 2015 Trial primary completion date: Aug 2014 --> Aug 2015
  • ||||||||||  Enrollment open:  PilAm Go4Health Weight Loss Program to Prevent Heart Disease (clinicaltrials.gov) -  Dec 13, 2014   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Dec 2014 --> Mar 2016 Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) (clinicaltrials.gov) -  Dec 10, 2014   
    P=N/A,  N=60, Recruiting, 
    Initiation date: Aug 2013 --> Nov 2013 Not yet recruiting --> Recruiting | Initiation date: Sep 2013 --> Sep 2014 | Trial primary completion date: Apr 2014 --> Sep 2015
  • ||||||||||  Trial completion:  PROMS-01: Probiotics and Endotoxemia (clinicaltrials.gov) -  Dec 10, 2014   
    P=N/A,  N=90, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: Sep 2013 --> Sep 2014 | Trial primary completion date: Apr 2014 --> Sep 2015 Active, not recruiting --> Completed
  • ||||||||||  Bydureon (exenatide XR once-weekly) / AstraZeneca
    Trial primary completion date:  TAO: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue (clinicaltrials.gov) -  Dec 6, 2014   
    P3,  N=50, Recruiting, 
    Trial primary completion date: Dec 2014 --> Jul 2015 Trial primary completion date: Jul 2014 --> Jun 2015
  • ||||||||||  atenolol / Generic mfg., bisoprolol / Generic mfg.
    Trial completion, Trial primary completion date:  CHAB: Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol (clinicaltrials.gov) -  Dec 6, 2014   
    P4,  N=80, Completed, 
    Trial primary completion date: Jul 2014 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Oct 2014
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  Canola Oil, Fibre and DHA Enhanced Clinical Trial (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=35, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jul 2013 Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Nov 2014 | Trial primary completion date: Apr 2015 --> Dec 2015
  • ||||||||||  Biomarker, Trial completion:  Micellar Curcumin and Metabolic Syndrome Biomarkers (clinicaltrials.gov) -  Dec 5, 2014   
    P2,  N=42, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Nov 2014 | Trial primary completion date: Apr 2015 --> Dec 2015 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  Effect of an Iridoid Enriched Beverage on Skin Autofluorescence (clinicaltrials.gov) -  Dec 5, 2014   
    P1,  N=34, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=48 --> 34
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Metabolic Syndrome in Patients With First-episode Schizophrenia (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=203, Completed, 
    Active, not recruiting --> Completed | N=48 --> 34 Recruiting --> Completed | N=100 --> 203 | Trial primary completion date: Dec 2012 --> Apr 2013
  • ||||||||||  New P1/2 trial, HEOR:  ENDOMETAB: ENDOBARRIER (clinicaltrials.gov) -  Nov 23, 2014   
    P1/2,  N=174, Recruiting, 
  • ||||||||||  Trial primary completion date:  Dairy Products and Metabolic Syndrome (clinicaltrials.gov) -  Nov 18, 2014   
    P=N/A,  N=153, Completed, 
    Recruiting --> Completed | N=100 --> 203 | Trial primary completion date: Dec 2012 --> Apr 2013 Trial primary completion date: Sep 2014 --> Jul 2013
  • ||||||||||  omega-3 ethylester concentrate / Generic mfg.
    Enrollment closed, Trial primary completion date:  Effects of Fish Oils on Inflammation and Insulin Resistance (clinicaltrials.gov) -  Oct 30, 2014   
    P=N/A,  N=135, Active, not recruiting, 
    N=122 --> 14 | Active, not recruiting --> Terminated; The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication. Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014
  • ||||||||||  Trial completion:  REWinD: Regulating Efficacy and Wellness in Diabetes (clinicaltrials.gov) -  Oct 30, 2014   
    P=N/A,  N=125, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014 Active, not recruiting --> Completed